Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow INDIVIOR PLC

Get SEC filing alerts via email and in your feed for INDIVIOR PLC

INDV INDV

INDIVIOR PLC

About INDIVIOR PLC

Indivior PLC is a global pharmaceutical company dedicated to transforming the treatment of substance use disorders (SUDs), particularly opioid use disorder (OUD). Its key products include SUBLOCADE, SUBOXONE Film, and OPVEE, addressing both OUD and opioid overdose. With a significant market opportunity driven by rising addiction rates, Indivior targets healthcare providers and patients in over 30 countries. The company emphasizes compliance and innovation, recently launching OPVEE and expanding SUBLOCADE's administration options.
This description was generated via AI from an annual report. Updated 8 months ago.
www.indivior.com

Latest SEC Filings from INDIVIOR PLC

1
1
INDIVIOR PLC Indivior Pharmaceuticals Reports 19% Revenue Growth to $317 Million in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
INDIVIOR PLC Indivior Reports 4% Revenue Growth and Strategic Changes for 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
INDIVIOR PLC Indivior PLC Reports Q3 2025 Financial Results with 2% Revenue Increase

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
INDIVIOR PLC Indivior PLC Reports $302 Million Net Revenue in Q2 2025, Driven by SUBLOCADE Sales

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
INDIVIOR PLC Indivior PLC Reports $266 Million Net Revenue in Q1 2025, Down 6% Year-Over-Year

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
INDIVIOR PLC Indivior PLC Reports $2 Million Net Income and 9% Revenue Growth for 2024

Via official filing (AI summary) | about 1 year ago | 0 comments